Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview Of Cell Separation And Isolation01:20

Overview Of Cell Separation And Isolation

6.6K
Cell separation was first achieved in 1964 by S. H. Seal, who separated large tumor cells from the smaller blood cells using filtration. Two years later, Pohl and Hawk performed experiments on how cells respond differently to a nonuniform electric field based on the cell type. Such observations were the inception of cell separation methods, which allow isolating a single cell type from a heterogeneous sample.
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delivery of DNA-encoded vaccines and proteins in mice using cutaneous suction-mediated transfection.

FEBS open bio·2026
Same author

Community Health Workers in Perinatal Mental Health: Feasibility and Challenges of Implementing a Task-Sharing Model.

Community mental health journal·2026
Same author

Acellular Normothermic Machine Perfusion Does not Exacerbate Acute Rejection in Rodent Vascularized Composite Allografts.

Transplantation direct·2026
Same author

Understanding the Complexities of Peripartum Mood and Anxiety Disorders: A Qualitative Assessment of Current Issues in Management and Treatment.

Maternal and child health journal·2026
Same author

Engineering single-vector logic-gated CAR T cells with transgene sizes beyond current limitations.

Journal for immunotherapy of cancer·2026
Same author

Chronopharmacology of AAV gene therapy in mice.

microPublication biology·2025

Related Experiment Video

Updated: Nov 5, 2025

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow
09:03

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

2.2K

Selecting a Cell Engineering Methodology During Cell Therapy Product Development.

Lauren M Timmins1, Alexandra M Burr1, Kristina Carroll1,2

  • 1Department of Biomedical Engineering, 242612Rutgers University, Piscataway Township, NJ, USA.

Cell Transplantation
|May 20, 2021
PubMed
Summary
This summary is machine-generated.

Developing genetically modified cell therapies requires careful consideration of engineering methods, risks, and clinical implications. This review guides developers in strategizing for safe and effective gene-based cell therapeutics.

Keywords:
cell therapygene therapygenetic engineeringmanufacturingproduct developmentviral vector

More Related Videos

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

22.5K
Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers
09:44

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Published on: July 7, 2023

4.2K

Related Experiment Videos

Last Updated: Nov 5, 2025

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow
09:03

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

2.2K
A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

22.5K
Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers
09:44

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Published on: July 7, 2023

4.2K

Area of Science:

  • Biotechnology
  • Cellular Therapeutics
  • Genetic Engineering

Background:

  • Developing genetically modified cell therapies necessitates aligning product engineering with intended human applications.
  • Commercialization requires careful selection of genetic modification methods based on practical factors.

Purpose of the Study:

  • To provide a strategic roadmap for developers of novel cell-based therapeutics.
  • To outline key considerations for initiating and managing risks associated with gene-based cell products.

Main Methods:

  • Review of biological, technological, manufacturing, and clinical factors in cell therapy development.
  • Analysis of risks and mitigation strategies for cell engineering approaches.

Main Results:

  • Identification of critical decision points in the development pathway for genetically modified cell therapies.
  • Emphasis on understanding the implications of permanent versus transient expression and manufacturing challenges.

Conclusions:

  • A comprehensive strategy integrating biological, technical, manufacturing, and clinical aspects is crucial for successful cell therapy development.
  • Thorough risk assessment and management are essential for gene-based cell therapeutic products intended for human use.